United Kingdom
I am a Project Manager with 13+ years of end-to-end clinical research project management and cross-functional team leadership experience, helping achieve key strategic objectives and drive development, regulatory and commercial results. As Head of Project Management for Richmond Pharmacology, I led project lifecycle management for multiple short and long-term clinical trials (FIH, Phase I, II and Japanese bridging studies) on behalf of international sponsors, managing multimillion-pound budgets. I oversaw contract negotiations, timeline development, scope planning, scenario analysis and priority management. Since joining Richmond Pharmacology in 2010, I orchestrated integrated project deliveries of 80+ complex clinical trials. Earlier in my career, I was a Project Coordinator for Sanofi, where I spearheaded a successful project delivery of the first foreign vaccine launch in Japan (ActHIB). My key areas of expertise include: • Senior Clinical Research Project Management • Cross-Functional Team Leadership • Senior Stakeholder Engagement • Scenario Analysis & Scenario Planning You can contact me at [email protected]
Lead project teams on clinical trials, orchestrating project plan preparation, management, maintenance, monitoring and alignment. Respond to RFPs and RFIs; prepare bids, proposals, and timelines. Execute adaptive priority management, manage project budgets, identify risks, and influence bid defence meetings. Coordinate project scope with clients to prepare integrated project plans. • Develop cohesive, high-performing teams by effectively training new project managers and driving teams toward successful issue resolution and timely decision making • Manage commercial project managers and work closely with medical, clinical, data management, volunteer recruitment, scheduling, laboratory, and marketing staff • Anticipate variability (budget, time, cost and risk) via scenario analyses to ensure rapid migration plan implementation and adapt team strategies accordingly
Directed 90% of projects as sole project manager over 6 months, leveraging agile decision making to manage competing priorities and identify acceleration opportunities. • Oversaw sponsor negotiations, contract creation (establishing SLAs), scope planning, project communications and escalation resolution • Received multiple client requests to lead future projects based on performance • Utilised strategic financial project management skills to meet targets and ensure revenue forecast accuracy; liaised with finance stakeholders to ensure consistent project delivery
Managed clinical trials through development lifecycle (study set-up, clinical phase, post-clinical activities, project close-out) on behalf of global sponsors. Led cross-functional teams as internal supervisor at project level. • Managed commercial elements of bridging studies sponsored by Japanese and American pharmaceutical companies • Ensured client satisfaction by managing expectations and proactively providing solutions • Selected, qualified, contracted, and managed third-party vendors. • Developed internal tools that were subsequently systematised across all studies
Led analysis of Hermes’ supply chain and sales forecasting system as a 3-month project on behalf of Bearing Point, a leading global consulting firm. Conducted organisation-wide problem solving and financial and analytic modelling to propose data-driven strategic and commercial recommendations. • Improved sales forecasting accuracy by liaising with marketing and purchasing departments to create refined forecasting method based on actual sales rather than minimum order quantities • Led operational process analyses to optimise stock management, resulting in reorientation of stock purchasing strategy and renegotiation of minimum order quantities with suppliers
Drove vaccine entry into Japanese market. Led in-depth qualitative and quantitative market analysis and overcame identified barriers to entry by coordinating medical, regulatory, marketing and finance teams. ● Spearheaded first foreign vaccine launch in Japan (ActHIB), exceeding sales targets by 200% ● Reduced supply timeframe from 16 to 10 weeks via strategic supplier negotiation ● Devised 5-10-year strategy defining vaccines to be developed for Japanese market